Otiprio ciprofloxacin otic suspension: Phase III started

Otonomy began a double-blind, sham-controlled, North American Phase III trial to evaluate a single dose of 12 mg Otiprio applied to the external ear canal in about 500 patients ages >=6 months. In Mar...